Inovio Pharmaceuticals logo

Inovio Pharmaceuticals Share Price (NASDAQ: INO)

$2.36

-0.1

(-4.07%)

Last updated on

Check the interactive Inovio Pharmaceuticals Stock chart to analyse performance

Inovio Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.34
    Today's High:$2.47

    Day's Volatility :5.27%

  • 52 Weeks Low:$1.30
    52 Weeks High:$7.55

    52 Weeks Volatility :82.78%

Inovio Pharmaceuticals Stock Returns

PeriodInovio Pharmaceuticals, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
12.62%
3.6%
0.0%
6 Months
28.53%
-7.7%
0.0%
1 Year
-63.22%
-12.6%
0.0%
3 Years
-91.54%
9.5%
-4.7%

Inovio Pharmaceuticals, Inc. Key Stats

Check Inovio Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.46
Open
$2.465
Today's High
$2.465
Today's Low
$2.335
Market Capitalization
$130.7M
Today's Volume
$1.2M
52 Week High
$7.5499
52 Week Low
$1.3
Revenue TTM
$182.3K
EBITDA
$-94.3M
Earnings Per Share (EPS)
$-2.59
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-140.12%

Stock Returns calculator for Inovio Pharmaceuticals Stock including INR - Dollar returns

The Inovio Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inovio Pharmaceuticals investment value today

Current value as on today

₹37,971

Returns

₹62,029

(-62.03%)

Returns from Inovio Pharmaceuticals Stock

₹67,313 (-67.31%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Inovio Pharmaceuticals Stock

-38%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Inovio Pharmaceuticals Stock from India on INDmoney has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Inovio Pharmaceuticals, Inc.

  • Name

    Holdings %

  • BlackRock Inc

    4.55%

  • Vanguard Group Inc

    3.94%

  • Deep Track Capital, LP

    3.88%

  • Bank of America Corp

    2.56%

  • Geode Capital Management, LLC

    1.66%

  • State Street Corp

    1.01%

Analyst Recommendation on Inovio Pharmaceuticals Stock

Rating
Trend

Buy

    55%Buy

    44%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Inovio Pharmaceuticals(by analysts ranked 0 to 5 stars)

Inovio Pharmaceuticals Share Price Target

What analysts predicted

Upside of 216.39%

Target:

$7.47

Current:

$2.36

Inovio Pharmaceuticals share price target is $7.47, a slight Upside of 216.39% compared to current price of $2.36 as per analysts' prediction.

Inovio Pharmaceuticals Stock Insights

  • Price Movement

    In the last 7 days, INO stock has moved up by 20.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 116.99K → 65.34K (in $), with an average decrease of 44.2% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -19.38M → -23.51M (in $), with an average decrease of 10.5% per quarter
  • INO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 137.1%
  • INO vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 204.0%
  • Price to Sales

    ForINO every $1 of sales, investors are willing to pay $473.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Inovio Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Inovio Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Inovio Pharmaceuticals, Inc. Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Inovio Pharmaceuticals, Inc. logo
66.55%
28.53%
-63.22%
-91.54%
-98.27%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Inovio Pharmaceuticals, Inc.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the University of Pennsylvania, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter BioLogics, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.
Organization
Inovio Pharmaceuticals
Employees
134
CEO
Dr. Jacqueline E. Shea Ph.D.
Industry
Health Technology

Key Management of Inovio Pharmaceuticals, Inc.

NameTitle
Dr. Jacqueline E. Shea Ph.D.
CEO, President & Director
Mr. Peter D. Kies
Chief Financial Officer
Dr. Michael Sumner M.D.
Chief Medical Officer
Dr. Laurent M. Humeau Ph.D.
Chief Scientific Officer & Chairman of the Scientific Advisory Board
Thomas Hong
Manager of Investor Relations
Mr. Robert L. Crotty J.D.
General Counsel, Corporate Secretary & Chief Compliance Officer
Mr. E. J. Brandreth MBA
Senior Vice President of Quality Assurance
Dr. Jeffrey Skolnik
Senior Vice President of Clinical Development
Mr. Robert J. Juba Jr.
Senior Vice President of Biological Manufacturing & Clinical Supply Management
Mr. Shawn D. Bridy M.A., M.B.A.
Senior Vice President of Business Development

Important FAQs about investing in INO Stock from India :

What is Inovio Pharmaceuticals share price today?

Inovio Pharmaceuticals share price today is $2.36 as on at the close of the market. Inovio Pharmaceuticals share today touched a day high of $2.47 and a low of $2.34.

What is the 52 week high and 52 week low for Inovio Pharmaceuticals share?

Inovio Pharmaceuticals share touched a 52 week high of $7.55 and a 52 week low of $1.30. Inovio Pharmaceuticals stock price today i.e. is closed at $2.36, lower by 68.74% versus the 52 week high.

How to invest in Inovio Pharmaceuticals Stock (INO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Inovio Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inovio Pharmaceuticals Shares that will get you 0.6356 shares as per Inovio Pharmaceuticals share price of $2.36 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Inovio Pharmaceuticals Stock (INO) from India?

Indian investors can start investing in Inovio Pharmaceuticals (INO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Inovio Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Inovio Pharmaceuticals share’s latest price of $2.36 as on August 30, 2025 at 1:29 am IST, you will get 4.2373 shares of Inovio Pharmaceuticals. Learn more about fractional shares .

What are the returns that Inovio Pharmaceuticals has given to Indian investors in the last 5 years?

Inovio Pharmaceuticals stock has given -98.27% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?